Description
Show Notes: https://eddyjoemd.com/methylene-blue-septic-shock/
Link to Lactic Acid Post: https://eddyjoemd.com/lactic-acid-sepsis/
In this episode, we discuss the use of methylene blue as a potential treatment for septic shock. We explore the science behind how methylene blue can help improve circulation and reduce inflammation in patients experiencing septic shock, and share a new study that was recently published in Critical Care. We break down the study and address common concerns and misconceptions about the use of methylene blue in this context, and discuss how we need additional research regarding its effectiveness and safety. If you're interested in learning more about cutting-edge treatments for sepsis and other critical illnesses, this episode is not to be missed.
Citation:
Ibarra-Estrada M, Kattan E, Aguilera-González P, Sandoval-Plascencia L, Rico-Jauregui U, Gómez-Partida CA, Ortiz-Macías IX, López-Pulgarín JA, Chávez-Peña Q, Mijangos-Méndez JC, Aguirre-Avalos G, Hernández G. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7. PMID: 36915146; PMCID: PMC10010212.
Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.
My website: www.eddyjoemd.com
Instagram: www.instagram.com/eddyjoemd
Twitter: www.twitter.com/eddyjoemd
Facebook: www.facebook.com/eddyjoemd
Podcast: https://anchor.fm/eddyjoemd
My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd
---
Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support
In this episode, we discuss recent findings on the potential risks of left atrial appendage closure (LAAC) in cardiac surgery patients without prior atrial fibrillation. The study highlights an increased risk of new-onset postoperative AF and prolonged hospital stays without clear benefits in...
Published 11/03/24
In this episode of the Saving Lives Podcast, Eddy Joe explores the TRISCEND II trial’s groundbreaking findings on transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. Learn about the quality-of-life improvements, procedural risks, and future directions for this...
Published 10/31/24